The FDA has rejected Sanofi's application seeking approval of tolebrutinib to treat certain forms of MS in its present form.
The festive period brought some unwanted post for both Sanofi and Corcept Therapeutics in the form of FDA rejections for the ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...
Saikat Chakrabarti, a hopeful replacement for Rep. Nancy Pelosi, is pitching a four-day workweek, citing Mark Zuckerberg’s ...
Fakeeh University Hospital is emerging as a global destination for advanced gene therapy, delivering highly specialized ...
For patients with oligometastatic cancers, particularly kidney or prostate, stereotactic body radiotherapy may frequently ...
Khaleej Times on MSN
Fakeeh University Hospital sets new benchmarks in advanced gene therapy
Fakeeh University Hospital is emerging as a global destination for advanced gene therapy, delivering highly specialised ...
Alsayegh, B. , Taso, O. , Dreidi, A. , Alzubi, A. and Alzwaherh, S. (2026) Complicated Gastroschisis with Progressive Fetal ...
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by harnessing the body's immune system to target ...
On a hill in north London, about 100 metres above sea level, is the capital’s only commercial scale vineyard, Forty Hall. It ...
A pharmaceutical company based in New Jersey that’s known for its FDA-approved treatment for ALS is set to be acquired for $2 ...
2don MSN
Boy, 5, Born with Rare Genetic Disorder Walks by Himself After Receiving World’s Most Expensive Drug
Megan Willis' son, Edward, was given the gene therapy, Zolgensma, after being diagnosed with spinal muscular atrophy when he ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback